文献速递炎症性肠病消化内镜

对糖蛋白2亚型1和4的免疫耐受丧失与储袋克罗恩病相关

Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.
PubMed 文献 · Aliment Pharmacol Ther · 2018-11-08

此项横断面研究纳入117例溃疡性结肠炎IPAA术后患者,采用酶联免疫吸附法盲法检测血清抗GP2亚型1和4的IgG与IgA及ASCA抗体。抗GP21 IgG、抗GP24 IgG和抗GP24 IgA的阳性率及水平与储袋克罗恩病特异性相关,而ASCA与储袋表型无关。作者认为抗GP2抗体可能有助于储袋克罗恩病的诊断。

要点

  • 抗GP21 IgG、抗GP24 IgG和抗GP24 IgA与储袋克罗恩病特异性相关。
  • 抗GP2抗体与内镜或组织学储袋疾病活动指数无关。
  • ASCA IgG和IgA的阳性率及水平与储袋表型无关。

核心结论

  • 新型抗GP21和GP24抗体与溃疡性结肠炎IPAA术后患者的储袋克罗恩病相关。
  • 血清抗GP2抗体可能有助于储袋克罗恩病的诊断。

研究设计与样本

  • 横断面研究,纳入117例连续接受回肠储袋肛管吻合术(IPAA)的溃疡性结肠炎患者。
  • 采用酶联免疫吸附法盲法检测血清抗GP2亚型1(GP21)和4(GP24)的IgG与IgA以及抗酿酒酵母(ASCA)IgG与IgA抗体。
  • 储袋疾病依据临床、内镜、组织学和影像学标准诊断;储袋克罗恩病定义为回肠储袋近端小肠黏膜受累、肛周并发症或回肠造口关闭后超过3个月出现储袋瘘。

主要发现

  • 抗GP21 IgG阳性率(AUC 0.77;P < 0.001)和水平(P = 0.02)与储袋克罗恩病特异性相关。
  • 抗GP24 IgG阳性率(AUC 0.74;P < 0.001)和水平(P = 0.025)与储袋克罗恩病特异性相关。
  • 抗GP24 IgA阳性率及水平(AUC 0.77;P < 0.001至P = 0.018)与储袋克罗恩病特异性相关。
  • 抗GP2抗体与内镜或组织学储袋疾病活动指数无关。
  • ASCA IgG阳性率(AUC 0.63;P = 0.12)和水平(P = 0.35)与储袋表型无关。

临床怎么用

  • 原文结论指出血清抗GP2抗体可能有助于储袋克罗恩病的诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Zymogen granule glycoprotein 2 (GP2) is a major autoantigen of Crohn's disease-specific pancreatic autoantibodies. AIM: To test a link between loss of tolerance to isoforms of GP2 and pouch disorders in a cross-sectional study in ulcerative colitis patients with ileal pouch-anal anastomosis (IPAA). METHODS: Serum samples of 117 consecutive ulcerative colitis patients after IPAA were tested for presence of Anti-GP2 isoforms 1 (GP21 ) & 4 (GP24 ) IgG and IgA as well as anti-Saccaromyces cervisiae (ASCA) IgG and IgA antibodies in a blinded fashion via enzyme-linked immunosorbent assay. Pouch disorders were diagnosed based on clinical, endoscopic, histological and radiographic criteria. Crohn's disease of the pouch was defined as involvement of the small bowel mucosa proximal to the ileal pouch with Crohn's disease, development of perianal complications or pouch fistula more than 3 months after ileostomy closure. RESULTS: Positivity and level of Anti-GP21 IgG (AUC 0.77; P < 0.001 & P = 0.02, respectively), Anti-GP24 IgG (AUC 0.74; P < 0.001 & P = 0.025, respectively) and Anti-GP24 IgA (AUC 0.77; P < 0.001 to P = 0.018, respectively) were specifically associated with Crohn's disease of the pouch. Anti-GP2 was not associated with endoscopic or histological pouch disease activity index. Neither positivity nor levels of ASCA IgG (AUC 0.63; P = 0.12 & P = 0.35, respectively) or ASCA IgA (AUC 0.67; P = 0.38 & P = 0.53) were associated with pouch phenotypes. CONCLUSIONS: The novel anti-GP21 and GP24 antibodies are associated with Crohn's disease of the pouch in ulcerative colitis patients after IPAA. Serological anti-GP2 antibodies could aid in diagnosis of Crohn's disease of the pouch.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Cummings D, Cruise M, Lopez R, et al. Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch. Aliment Pharmacol Ther. 2018. PMID: 30411391. doi:10.1111/apt.15034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。